ArticleUrology2014

Androgen receptor CAG repeat length and TMPRSS2:ETS prostate cancer risk: results From the Prostate Cancer Prevention Trial.

William D Figg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.